Follow

Submissions from 2016

Link

Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks, J. J. Feld, C. Moreno, R. Trinh, E. Tam, S. Bourgeois, Y. Horsmans, M. Elkhashab, D. E. Bernstein, N. S. Shulman, F. Poordad, and +7 additional authors